iShares Biotechnology ETF (NASDAQ:IBB) Stake Lessened by Canton Hathaway LLC

Canton Hathaway LLC trimmed its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,861 shares of the financial services provider’s stock after selling 190 shares during the quarter. Canton Hathaway LLC’s holdings in iShares Biotechnology ETF were worth $1,436,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in IBB. Jane Street Group LLC bought a new stake in shares of iShares Biotechnology ETF in the 1st quarter valued at approximately $14,386,000. Cetera Investment Advisers raised its holdings in shares of iShares Biotechnology ETF by 689.4% during the first quarter. Cetera Investment Advisers now owns 91,078 shares of the financial services provider’s stock worth $12,498,000 after purchasing an additional 79,541 shares during the period. State of Michigan Retirement System lifted its position in shares of iShares Biotechnology ETF by 150.0% in the 2nd quarter. State of Michigan Retirement System now owns 125,000 shares of the financial services provider’s stock worth $17,158,000 after buying an additional 75,000 shares during the last quarter. Aristides Capital LLC acquired a new position in shares of iShares Biotechnology ETF in the 2nd quarter valued at about $9,180,000. Finally, Sanctuary Advisors LLC bought a new stake in shares of iShares Biotechnology ETF during the 2nd quarter valued at about $8,118,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Up 0.8 %

IBB opened at $139.00 on Monday. The company’s 50-day moving average price is $143.43 and its 200 day moving average price is $141.87. iShares Biotechnology ETF has a fifty-two week low of $117.28 and a fifty-two week high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The business also recently declared a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were issued a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.